Used as a potent inhibitor in pharmaceutical formulations targeting inflammatory diseases and autoimmune disorders. Its primary application lies in the development of treatments for rheumatoid arthritis and psoriasis due to its ability to selectively modulate immune cell signaling pathways. The compound demonstrates high efficacy in reducing cytokine production and T-cell activation, making it valuable in chronic inflammatory conditions. It is also investigated for use in oncology, particularly in hematological malignancies, where immune modulation plays a critical role. Due to its stability and bioavailability, it is suitable for oral dosage forms in clinical settings.